These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 650992)

  • 1. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. First report: Urinary fibrin/fibrinogen degradation products in primary glomerulonephritis (author's transl)].
    Miyamura S
    Nihon Jinzo Gakkai Shi; 1978 Jan; 20(1):67-78. PubMed ID: 650992
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary excretion of plasmin and fibrin-fibrinogen degradation products in various types of glomerulonephritis (author's transl)].
    Koyama A; Narita M; Ishida H; Fukao K; Tojo S
    Nihon Jinzo Gakkai Shi; 1979 Sep; 21(9):1037-46. PubMed ID: 160473
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary fibrin/fibrinogen degradation products (FDP) in chronic glomerulonephritis].
    Shimamatsu K
    Fukuoka Igaku Zasshi; 1986 Sep; 77(9):480-9. PubMed ID: 3804170
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. Second report: Urinary fibrin/fibrinogen degradation products in nephrotic syndrome. (author' transl)].
    Miyamura S
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):315-26. PubMed ID: 671855
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of fibrin/fibrinogen degradation products in primary glomerular disease (author's transl)].
    Kazuta Y
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):383-95. PubMed ID: 671857
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP
    N Z Med J; 1977 Oct; 86(597):332-4. PubMed ID: 272538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary cross-linked fibrin degradation products in glomerular disease with crescents.
    Kamitsuji H; Matsunaga K; Taira K; Nakajima M; Whitworth JA; Kincaid-Smith P
    Clin Nephrol; 1988 Mar; 29(3):124-8. PubMed ID: 3359703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of urinary fibrin-fibrinogen degradation products (FDP) in various infantile glomerular nephorapathies].
    Tamborine G; Barbieri U; Forese S; Cocconcelli P; Zervos N
    Minerva Pediatr; 1977 Mar; 29(8):525-8. PubMed ID: 865431
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary crosslinked fibrin degradation products in various renal diseases].
    Kamitsuji H; Whitworth JA; Kincaid-Smith P
    Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1137-43. PubMed ID: 3807046
    [No Abstract]   [Full Text] [Related]  

  • 12. [The investigation on early diagnosis of the bladder tumor. I: A study on urinary cytology and urinary fibrin/fibrinogen degradation products (FDP) assay in patient with bladder tumor (author's transl)].
    Tanahashi T
    Nihon Hinyokika Gakkai Zasshi; 1979 May; 70(5):553-62. PubMed ID: 470263
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrin degradation products in the urine in renal diseases].
    Iversen BM; Ofstad J; Thunold S; Willassen Y
    Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
    Shibata T; Magari Y; Mizunaga S; Okabe E; Sumie A; Ishii T; Tomo T; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of urinary fibrin-fibrinogen degradation products in renal disease].
    Umitsu Y
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):371-87. PubMed ID: 988340
    [No Abstract]   [Full Text] [Related]  

  • 16. [Urinary excretion of fibrin degradation products in children with nephrotic syndrome (author's transl)].
    Bouissou F; Barthe P; Boneu B
    Arch Fr Pediatr; 1980 Mar; 37(3):167-71. PubMed ID: 7469695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary fibrinogen degradation products and differential protein clearances in renal disease.
    Blainey JD; Terry JM
    Clin Nephrol; 1979 Mar; 11(3):140-1. PubMed ID: 436342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The investigation on early diagnosis of the bladder tumor. II: A study on urinary cytology, urinary fibrin/fibrinogen degradation products, tissue fibrin deposition and tissue plasminogen activator activity in patients with bladder tumors (author's transl)].
    Tanahashi T
    Nihon Hinyokika Gakkai Zasshi; 1980 Sep; 71(9):1047-54. PubMed ID: 7193258
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
    Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
    Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.